February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 11, 2025

Contraceptives Show Varying Clot Risks

A study of 1.4 million women reveals that combined hormonal contraceptives carry the highest blood clot risk while IUDs show no increased risk compared to non-use.

Conexiant

January 30, 2025

FDA Approves New Dual-Action Drug for Migraine

SYMBRAVO (meloxicam and rizatriptan) has received U.S. Food and Drug Administration approval for the acute treatment of migraine with or without aura in adults.

Conexiant

May 08, 2024

ObGyn Harassment Prevalence Exposed in Revealing Review

Discover key insights from a systematic review on harassment among ObGyn health care professionals.

Conexiant

August 09, 2024

Updated Guidance on Contraceptive Use

The CDC has released updated contraceptive guidance for health care providers, emphasizing patient autonomy and evidence-based recommendations to support high-quality, equitable contraceptive care.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

June 26, 2024

FDA Releases Guidance for Drugmakers on Diversity in Clinical Studies

The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.

Conexiant

May 13, 2024

Abortion Ban Impact on Residency Applicants: ACOG Weighs In

ACOG "is thankful for the passion and the commitment of those future obstetrician–gynecologists who have demonstrated a fierce dedication to the field in the face of dangerous legislative interference."

Conexiant